• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.45% Nasdaq Up0.40%

    Celsion Corp. (CLSN)

    1.51 Down 0.03(1.95%) 4:00PM EDT
    ProfileGet Profile for:
    Celsion Corp.
    997 Lenox Drive
    Suite 100
    Lawrenceville, NJ 08648
    United States - Map
    Phone: 609-896-9100
    Fax: 609-896-2200
    Website: http://www.celsion.com

    Index Membership:N/A
    Full Time Employees:28

    Business Summary 

    Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company’s lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. Ltd. for ThermoDox; and a commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. Ltd. for the production of ThermoDox in mainland China, Hong Kong, and Macau. The company was founded in 1982 and is based in Lawrenceville, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Celsion Corp.

    Key Executives 
    Mr. Michael H. Tardugno , 65
    Chairman, Chief Exec. Officer and Pres
    Mr. Jeffrey W. Church CPA, 59
    Chief Financial Officer, Sr. VP of Corp. Strategy & Investor Relations and Corp. Sec.
    Dr. Khursheed Anwer Ph.D., M.B.A. , 56
    Chief Scientific Officer and Exec. VP
    Dr. Nicholas Borys M.D., 57
    Chief Medical Officer and Sr. VP
    Mr. Timothy J. Tumminello CPA, 58
    Chief Accounting Officer and Controller
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders